MXRA5 and chronic kidney disease: Overall, the dual anti‐inflammatory and anti‐fibrotic activity of MXRA5 suggests that this is a molecule of potential therapeutic interest and that MXRA5 up‐regulation in CKD may be an adaptive response that breaks inflammation and fibrosis.